Researchers have made a potentially significant advancement in cancer treatment by developing a novel class of X-ray-sensitizers that they believe could revolutionise radiotherapy.
Their study highlights how specific organic pharmaceutical drug intermediates, derived from thioxanthone (TX), can…
[ad_2]
Source link
